Gyros AB Appoints Dr. Claus Braestrup to the Board of Directors
News Jan 28, 2013
He is also a Member of the Advisory Board of Nordic Biotech and BankInvest BioMedical Venture. Dr. Braestrup is a Member of The Royal Danish Scientific Society and The Academy of Technical Sciences. He holds M.Sc. degrees in Chemical Engineering and Biochemistry, and a Doctorate in Medical Science from the University of Copenhagen.
Dr. Braestrup was previously President and Chief Executive Officer at H. Lundbeck A/S. He also formerly held the positions of Vice President of Pharmaceutical Research, President of the CNS Division, and President of the Diabetes Care Division at Novo Nordisk A/S, and Head of Preclinical Drug Research with Schering AG.
Erik Walldén, CEO at Gyros, commented: “We welcome Claus to the Board of Directors. His excellent scientific background and many years’ experience within the biotech and pharmaceutical industry will be a great asset to Gyros.”
Dielectrophoresis Chromatography Could Advance Laboratory AnalysisNews
Research being done at Rochester Institute of Technology to refine lab-on-chip devices—highly sophisticated laboratories on microchips—will provide more detailed and timely information to detect diseases such as cancer.READ MORE
New Test Reveals Antibiotic-Resistant Bacteria in 30 MinutesNews
The new procedure shortens wait times from three days and could help reduce the spread of superbug bacteria.READ MORE